Milestone Pharmaceuticals Inc (MIST) financials · $160.6M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Milestone Pharmaceuticals Inc (MIST) $160.6M cap.
| Line | FY2025 | FY2024 | Pro (2 older periods with Lician Pro) |
|---|---|---|---|
| Operating Income | −$62.14M | −$42.10M | |
| Net Income | −$63.06M | −$41.52M | |
| EPS (Diluted) | −$0.75 | −$0.67 | |
| Unlock 5 years of statements: Lician Pro $149/yr | |||
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Total Assets | $113.56M | $75.50M | |
| Current Assets | $111.92M | $73.93M | |
| Cash & Equivalents | $73.05M | $25.31M | |
| Inventory | $648.00K | — | |
| PP&E | $511.00K | $197.00K | |
| Total Liabilities | $71.79M | $62.35M | |
| Current Liabilities | $13.98M | $8.13M | |
| Long-term Debt | $57.19M | $53.35M | |
| Total Debt | $57.19M† | $53.35M† | |
| Shareholders' Equity | $41.77M | $13.15M | |
| Retained Earnings | −$430.60M | −$367.55M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 | Pro (3 older periods with Lician Pro) |
|---|---|---|---|
| Operating Cash Flow | −$49.04M | −$28.85M | |
| CapEx | $302.00K | $33.00K | |
| Investing Cash Flow | $11.25M | $8.28M | |
| Financing Cash Flow | $85.53M | $32.12M | |
| Net Change in Cash | $47.73M | $11.55M | |
| Free Cash Flow | −$49.34M | −$28.88M |
Source: Company filings with the SEC (EDGAR) · Latest period FY2025
FAQ
What is MIST P/E and revenue?
Milestone Pharmaceuticals Inc (MIST) $160.6M cap.
What is MIST revenue?
MIST income-statement cache has no revenue figure yet.
Is MIST profitable?
Milestone Pharmaceuticals Inc last cached net income is -$63.1M (FY2025).
What are MIST total assets?
Milestone Pharmaceuticals Inc last cached total assets are $113.6M (FY2025).
What is MIST free cash flow?
Milestone Pharmaceuticals Inc last cached free cash flow is -$49.3M (FY2025).
Not investment advice. Figures as reported in company filings, not a live feed.